A review of sex-specific benefits and risks of antithrombotic therapy in acute coronary syndrome
Key result
Antithrombotic therapy in acute coronary syndrome yields similar benefits for men and women, though women face a consistently higher risk of bleeding and suboptimal medication dosing.
Why the study?
Are there sex-specific differences in the benefits and risks of antithrombotic therapy in patients with acute coronary syndrome?
Population
Male and female patients with acute coronary syndrome (ACS)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May warrant closer bleeding monitoring for women on ACS antithrombotics; leaves open optimal sex-specific dosing strategies.
Structured PICO
Are there sex-specific differences in the benefits and risks of antithrombotic therapy in patients with acute coronary syndrome?
P
Population
Male and female patients with acute coronary syndrome (ACS)
E
Exposure
Antithrombotic therapy
O
Outcome
Thrombotic events and bleeding risk
This review highlights that while women with ACS derive similar benefits from antithrombotic therapy as men, they face higher bleeding risks and disparities in dosing and adherence, necessitating sex-specific management strategies.
Cite This Study
Wang et al. (2016) conducted a review in Acute coronary syndrome. Antithrombotic therapy was evaluated. Antithrombotic therapy in acute coronary syndrome yields similar benefits for men and women, though women face a consistently higher risk of bleeding and suboptimal medication dosing.